Your white-label peptide telehealth platform, live in days
Your customers complete an online intake, licensed providers review and prescribe, and regulated pharmacies ship to their door. FUSE is the peptide telehealth platform running all of it behind your brand, so you never have to build it.
70 visit types · 50-state provider coverage · 503A/503B sourcing · fully white-label
What is peptide telehealth?
Peptide telehealth is the prescription route to peptides: a patient completes an online intake, a licensed clinician reviews and prescribes, and a regulated pharmacy ships telehealth peptides to their door. FUSE runs that entire route behind your brand, so operators can sell it without building it.
Research-use-only e-commerce
“Not for human use” powder with no clinician and no patient labeling — delisting and processor risk baked in.
Prescription peptide telehealth
A licensed clinician reviews every intake; a named 503A/503B pharmacy fills and ships — under your brand, on your domain.
Why peptide telehealth platforms need LegitScript certification.
Card processors and ad platforms treat peptide telehealth as high-risk — without LegitScript certification, Stripe accounts and Meta ads get shut down. It is the same gate every white-label telehealth operator hits, peptides or not.
The five telehealth peptide programs your brand can run
Five program categories, one customer base. Every telehealth peptide order is filled by a licensed 503A or 503B pharmacy — and the operators who win move the same customer across programs.
Where most launches start: GLP-1 programs with monthly refill cycles that make revenue recurring from the first customer.
Weight-loss customers become longevity and skin subscribers — the cross-sell that turns one program into three.
Med spas, supplement brands, and weight-loss coaches.
How a peptide telehealth order moves from intake to doorstep
Four steps from intake to doorstep. None are performed by your team, and all are visible in your operator dashboard.
Async intake
Your customer completes a structured medical intake on your storefront — no video visit, no scheduling friction.
Independent review
A licensed clinician in the customer's state reviews the intake and makes the prescribing decision — approve, adjust, or decline.
Pharmacy fill
A 503A or 503B compounding pharmacy fills the prescription. Reconstitution happens at the pharmacy — never in your customer's kitchen.
Direct fulfillment
The pharmacy ships direct to your customer with tracking, and refill cycles run themselves. The box is the pharmacy’s; the white-label experience is everything around it — storefront, emails, refill cycle, support.
What protects your brand when the label is white-label
Operators in this space don’t lose sleep over regulators first — they lose sleep over a bad vial with their brand on it. The compliant route exists precisely to remove that risk.
- Prescription-grade compounding — not research-use-only powder with a logo
- Every order traces to a licensed provider's decision and a named pharmacy
- Catalog guardrails maintained as the rules move — quarter by quarter
Who runs peptide telehealth programs on FUSE
Four kinds of operator, one set of rails behind all of them.
Med spas & clinics
GLP-1 and recovery programs for clients who already buy injectables.
Coaches & fitness brands
A compliant answer when clients ask about peptides — with your name on it.
Longevity & wellness brands
Sermorelin, NAD+, and healthy-aging protocols sold as subscriptions.
Supplement & e-comm brands
The step up from research-use-only gray areas to prescription rails.
Wherever you are in the research, it converges here
Guides answer the questions. Comparisons pick the vendor. This page is where the peptide route gets specific.
Start with the guides
Peptide telehealth, on rails
Prescribers, pharmacies, payments, and compliance — one layer behind your storefront, live in 3–5 business days.
Go deeper on peptides
Explore Resources
503A vs 503B: Which Pharmacy for Your Program?
How the two compounding routes differ — and when each fits.
6 min read·Read article
From Research-Use-Only to Prescription: Making the Switch
Moving a gray-area catalog onto compliant prescription rails.
7 min read·Read article
Pricing a Peptide Program: Margin Math for Operators
Set retail prices that keep the margin yours.
8 min read·Read articleCreator Launches a Longevity Brand in a Weekend
From audience to a live subscription program in days.
5 min read·Read articleAsync Intake, Explained for Non-Clinical Founders
What happens between the storefront and the prescription.
6 min read·Read articleWhich Peptides Are Legal? The Operator's Guide
The maintained Category 1 vs 2 table, updated with dates.
12 min read·Read articleFAQs
What operators ask before launching a peptide program.
What is a peptide telehealth platform?
The prescription route to peptides, packaged as infrastructure: online medical intake, independent licensed clinicians who review each case, and 503A/503B compounding pharmacies that fill and ship every order. FUSE runs that entire flow behind your brand.
Is it legal to sell peptides through telehealth?
There are two routes in this market: research-use-only e-commerce, and the prescription route — where licensed clinicians evaluate each patient and regulated compounding pharmacies fill the orders. FUSE operates the second. Which peptides qualify changes quarter to quarter; the maintained legality guide tracks Category 1 vs Category 2 with dates.
Which peptides can my brand offer?
FUSE organizes peptide demand into five program categories: weight loss and metabolic (GLP-1 programs), recovery and repair, hormone and longevity, sexual health, and skin, hair, and immune. Which specific peptides are compounding-eligible shifts with FDA guidance and varies by state — the maintained legality guide tracks current status with dates, and the independent clinician reviewing each intake makes the final call.
Who actually prescribes?
Independent licensed clinicians in the customer's state — never FUSE, and never you. They review every intake and make every prescribing decision: approve, adjust, or decline. Your brand fronts the experience; the clinical decision stays with the provider.
Where do the peptides come from?
503A and 503B compounding pharmacy partners fill each prescription. Reconstitution is handled at the pharmacy, and every order traces to a named provider and a named pharmacy — the difference between prescription-grade compounding and research-use-only powder.
How fast can I launch, and what does it cost?
3–5 business days from signup to a live storefront on your own domain. Growth is $699/month and Pro is $3,000/month — flat rates with no per-visit fees, published in full on the pricing page.
What should I look for in a peptide telehealth platform?
Six things: who employs the prescribing clinicians and in which states, whether the pharmacy network is 503A, 503B or both, who holds the LegitScript certification, whether pricing is published, how long launch actually takes, and what happens when you want to sell beyond peptides. Platforms that will not answer the first or third question in writing are the ones to walk away from.
Do I need a medical license to run a peptide telehealth program?
No. Independent licensed clinicians make every prescribing decision and a licensed pharmacy fills every order. You own the brand and the customer relationship; the clinical layer stays with the providers. The same structure applies across white label telehealth generally, not only peptides.
Is this the same as white label peptides?
No, and the difference matters. White label peptides usually means buying research-use-only vials in bulk and putting your logo on them — no clinician, no patient labeling, and real exposure with payment processors. Peptide telehealth is the prescription route: a licensed clinician reviews every intake and a 503A or 503B pharmacy fills every order. FUSE only operates the second.
Your peptide brand, live this week
Prescribers, pharmacies, payments, and compliance — the rails are already built. Your brand goes live on them in 3–5 business days.
Independent licensed clinicians make all prescribing decisions on programs powered by FUSE. FUSE does not prescribe, diagnose, or treat patients. Prescription products require evaluation by a licensed provider. Specific peptide availability varies by state and is determined by independent clinicians and pharmacy partners.